Myocarditis

Area of Science:

• Cardiology
• Internal Medicine
• Pediatrics

Background:

• Myocarditis and dilated cardiomyopathy (DCM) are significant causes of illness and death, particularly in pediatric and young adult populations.
• These conditions present with diverse symptoms, including heart failure, arrhythmias, and chest pain, often necessitating a broad differential diagnosis.

Purpose of the Study:

• To emphasize the importance of considering myocarditis in patients presenting with unexplained cardiac symptoms.
• To outline diagnostic strategies, including endomyocardial biopsy (EMB), and therapeutic approaches for myocarditis and DCM.
• To guide management decisions for patients with varying disease severity and clinical presentations.

Main Methods:

• Clinical assessment for symptoms of heart failure, arrhythmia, or chest pain.
• Consideration of endomyocardial biopsy (EMB), potentially requiring multiple or serial procedures for diagnostic sensitivity.
• Hospitalization for evaluation and treatment of symptomatic patients.
• Application of conventional heart failure therapies (ACE inhibitors, digitalis, diuretics, beta-blockers).
• Electrophysiologic evaluation for patients with arrhythmias or syncope.
• Consideration of immunosuppressive therapy in select cases.
• Close monitoring of clinical course, treatment response, and left ventricular function.
• Early referral for advanced heart failure management, including ventricular assist devices and cardiac transplantation, for severe cases.

Main Results:

• Diagnosis of myocarditis may require multiple or serial endomyocardial biopsies to achieve sufficient sensitivity.
• Conventional heart failure therapies are recommended for patients with symptomatic left ventricular dysfunction.
• Immunosuppressive therapy may be beneficial in specific patient cohorts.
• Patients with rapidly progressive heart failure or cardiogenic shock require advanced interventions such as ventricular assist devices or cardiac transplantation.

Conclusions:

• Myocarditis should be a key consideration in the differential diagnosis of acute cardiac syndromes in all age groups.
• Timely diagnosis, including EMB, and tailored treatment, encompassing conventional and potentially immunosuppressive therapies, are essential for improving outcomes.
• Aggressive management, including advanced heart failure support, is critical for patients with severe or progressive disease.